Introduction
Diabetic nephropathy, the leading cause of end-stage renal disease in North America, is characterized by proteinuria, diminished glomerular filtration rate, podocyte injury, mesangial matrix accumulation, progressive glomerulosclerosis and tubulointerstitial disease (41, 52) . Increased local expression of peptide growth factors, such as angiotensin II, transforming growth factor-(TGF) and vascular endothelial growth factor (VEGF), is implicated in these pathological abnormalities (41, 52) . Longterm clinical trials of individuals with type I and type II diabetes have demonstrated that hyperglycemia is a causal factor for the development of diabetic nephropathy (13, 48) .
The biochemical actions of intracellular high glucose may be initiated by the generation of reactive oxygen species in the mitochondria and the ensuing increased flux through side pathways in glycolysis (7) . This leads to activation of protein kinase C (PKC), advanced glycation end-product (AGE) formation and other effects. However, the molecular mechanisms linking these earliest effects of high glucose to the excess expression and secretion of peptide growth factors remain incompletely understood.
VEGF (also called VEGF-A) is a member of a family of secreted, 34-42 kDa, dimeric glycoproteins related to the platelet-derived growth factor family (8, 43) . VEGF potently stimulates vasculogenesis, angiogenesis, microvascular permeability, and nitric oxide release by binding to one of two tyrosine kinase receptors, VEGFR1 (also called Flt-1) and VEGFR2 (Flk-1) on endothelial cells (15) . Alternate splicing produces a number of different isoforms, of which VEGF165 and VEGF164 are the most abundant in humans (15) and rats (38) , respectively. High glucose causes upregulation of VEGF in Page 3 of 39 (10, 12, 44, 51) , whereas, VEGFR2 receptors are expressed mainly on glomerular endothelial cells (12) .
mesangial cells and podocytes in vivo
Mesangial cell PKC-, , , and are activated in high glucose, presumably through de novo diacylglycerol synthesis (2, 21, 25) . Indeed, PKC-is necessary for the development of experimental diabetic nephropathy in rodents, as shown by studies with a specific PKC inhibitor, ruboxistaurin (LY333531), and more recently with PKCknockout mice (24, 32) . Although diacylglycerol does not modulate PKC-directly, PKC-activity is elevated in the presence of high glucose, as assessed by membrane translocation and an in vitro kinase activity of PKC-immunoprecipitated from mesangial cell membranes (2, 14, 27) . In turn, PKC-contributes to high glucoseinduced filamentous actin disassembly, the generation of reactive oxygen species (ROS) from NADPH oxidase, and is required for enhanced collagen IV expression (14, 27 VEGF is of particular interest because of its possible autocrine and paracine action in altering glomerular permeability and causing proteinuria in diabetic nephropathy. The present study was designed to further elucidate the mechanisms responsible for the enhanced expression and secretion of VEGF in high ambient glucose using mesangial cells as a model. We postulated that in mesangial cells exposed to high glucose upregulation of VEGF expression was related to the earliest glucose-induced signaling mechanisms involving ROS and PKC isozymes. Here, we demonstrate a requirement for NADPH oxidase-induced ROS and for two protein kinase C isoforms, -1 and -, in high glucose-stimulated VEGF synthesis and secretion.
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Materials and Methods
Materials
Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl) was obtained from Sigma (St. Louis, MO). Gö6976 was purchased from EMD Biosciences (San Diego, CA).
LY333351 was from Axxora (San Diego, CA). The myristoylated PKC-inhibitor (myr-RRGARRWRK), the p22 phox phosphorothioate antisense oligonucleotides (5'-GAT CTG CCC CAT GGT GAG GAC C-3'), and all the primers for real-time polymerase chain reaction (PCR) were synthesized by The Center for Applied Genomics at The Hospital for Sick Children (Toronto, ON, Canada).
Cell Culture
Rat mesangial cells were isolated and grown as we have previously described (20, 53). The cells were routinely growth-arrested in 0.5 % fetal bovine serum for 48 h prior to the start of experiments. Louis, MO) and HIF-1 (Novus Biologicals, Littleton, CO) as we previously described (20, 27, 53).
Plasmids and Mesangial Cell Transfection
Total cell lysates and cellular membrane fractions were prepared as previously reported (14, 53) . A mesangial cell crude nuclear fraction was obtained by lysing cells in 50 mM Tris-HCl, pH 7.5, 10 mM EGTA, 2 mM EDTA, 1 mM benzamidine, 1 mM NaF, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride and 25 ug/ml leupeptin. Using a chilled 1 ml Dounce homogenizer, the lysates were processed with 5 strokes using a "loose" pestle and then 5 strokes with a "tight" pestle to separate the nuclei. The lysate was then centrifuged at 4 O C at 500 X g for 10 min X 3 with resuspension in the above buffer. Then, the nuclear enriched pellet was suspended in the above buffer with the addition of 1% Triton-X 100, passed 5X through a 26 g needle and centrifuged at 15,000 X g for 5 min. The supernatant was used as the nuclear-enriched fraction.
VEGF mRNA measured by Real-Time PCR
RNA was isolated from mesangial cells using an RNeasy kit (Qiagen, Valencia, CA). The RNA was reverse transcribed and subject to real-time PCR as we have described (53) . The primers for VEGF were VEGF (sense), 5'-GATGAGATAGAGTATATCTTCAAGCCGT-3'; VEGF (antisense), 5'-TCTATCTTTCTTTGGTCTGCATTCAC-3' (GenBank: NM_031836). To measure VEGF mRNA stability, mesangial cells were treated with 5 µg/ml actinomycin D and RNA was harvested and analyzed for VEGF mRNA levels by real-time PCR as we previously described (53) .
PKC-1 Kinase Assay
PKC-1 activity was measured in total mesangial cell lysates, cellular membrane fraction and the crude nuclear fraction as prepared above. The solublized samples were immunoprecipitated in the following buffer; 25 mM Hepes, 150 NaCl, 1 mM EGTA, 2 mM EDTA, 10 mM NaF, 50 mM B-glycerophosphate, 1 mM sodium orthovanadate, 1% Triton-X 100, 1 mM phenylmethylsulfonyl fluoride and 25 ug/ml leupeptin. PKC-1 was immunoprecipitated with 2 ug anti-PKC-1 antibody (Santa Cruz) and 65 ul protein G Plus Agarose. The purified PKC-1 samples were used for an in vitro kinase assay as we previously described for PKC-, using a MARCKS peptide substrate (Biomol, Plymouth
Meeting, PA) (27).
Enzyme-linked immunosorbent assay (ELISA) for VEGF
The concentration of VEGF164 was measured in the conditioned media of cultured mesangial cells using a kit from R&D Systems (Minneapolis, Minn., USA)
according to the manufacturer's instructions.
Statistical Analyses
Results are expressed as mean ± SEM. Statistical analyses were performed with Instat 2.01 (Graph Pad, Sacramento, CA, USA). Unpaired Student t tests were used to compare the means of two groups and analysis of variance was applied to compare the means of three or more groups followed by the Tukey-Kramer post hoc test. p < 0.05 was considered to be significant.
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Results
High Glucose Stimulates Mesangial Cell VEGF Expression
To investigate the regulation of VEGF, rat mesangial cells were exposed to either 5.6 mM (normal glucose) or 25 mM glucose (high glucose) for up to 48 h. As displayed in Figure 1A , cellular VEGF protein levels, determined by Western blotting, were significantly increased (1.75-fold) by 3 h. This was not due to an osmotic effect, since 25 mM D-glucose but not 19.4 mM L-glucose plus 5.6 mM D-glucose increased VEGF immunostaining in mesangial cells ( Figure 1B ). Figure 1C shows that VEGF protein levels were increased by D-glucose concentrations as low as 15 mM. Secreted VEGF164
detected by ELISA was significantly increased in response to high glucose in mesangial cell media after 24 h and was 2.5-fold higher by 48 h ( Figure 1D ).
VEGF mRNA levels, assessed by real-time quantitative PCR, were significantly increased at 3 h in high glucose and were 2.5-fold higher by 48 h ( Figure 1E ). VEGF gene expression is regulated by transcriptional activation and through changes in mRNA stability, as observed in AMP-activated protein kinase-stimulated myotubes (34) .
Therefore, mesangial cells were incubated with 5.6 or 25 mM glucose for 6 h, treated with actinomycin D to stop transcription, and VEGF mRNA levels monitored by PCR. Figure 1F shows that high glucose did not reduce the decay rate of VEGF mRNA following the addition of actinomycin-D, indicating that high glucose does not increase VEGF mRNA stability. Figure 3A) . Interestingly, knocking down p22 phox expression blocked the increase in VEGF protein in high glucose detected by both Western blotting ( Figure 3A ) and immunostaining ( Figure 3B ). Further supporting a role for NADPH oxidase, transiently overexpressing p22 phox was sufficient to upregulate VEGF expression in normal glucose ( Figure 3C ).
High Glucose-induced VEGF Expression Is Dependent On ROS Generated By NADPH Oxidase
The Role of PKC-1 and -In High Glucose-stimulated VEGF Expression
One of the fundamental consequences of exposure to high glucose is increased diacylglycerol synthesis and activation of conventional and novel PKC isozymes (see above). Indeed, certain PKC isozymes are necessary for NADPH oxidase activity and collagen IV expression in mesangial cells (19, 27, 53) . Accordingly, we explored the To better define the role of PKC-1 , we sought evidence that PKC-1 is activated by high glucose under the present experimental conditions. In mesangial cells incubated in 25 mM glucose for 3 hours, the amount of PKC-1 was increased in whole cell extracts and slightly increased in crude nuclear fractions, which include some associated endoplasmic reticulum membrane fractions, relative to cells maintained in 5.6 mM glucose ( Figure 5A ). In preliminary experiments, PKC-1 in vitro kinase activity was assayed in immunoprecipitates and found to be modestly increased in total cell lysates and cellular membrane fractions in high glucose compared to normal glucose conditions (not shown). As displayed in Figure 5B , the in vitro kinase activity of PKC-1 immunoprecipitated from crude nuclear fractions was 3.8-fold higher in cells exposed to 
HIF-1 Expression in high glucose
Hypoxia inducible factor -1 (HIF- 
Discussion
It is well established that high ambient glucose concentrations lead to enhanced VEGF expression, but only limited information is available on the mechanisms involved.
Using mesangial cells as a model, we observed that high glucose enhanced VEGF expression both at the protein level, detected by Western blotting, immunofluorescence, and ELISA, and at the mRNA level, detected by PCR. This latter effect was not due to increased RNA stability.
The present results demonstrate for the first time that ROS generated by NADPH These seemingly disparate results may be explained by mutual interactions between mitochondria-generated ROS and NADPH oxidase causing both to be necessary for high glucose-induced ROS formation. Thus in glomerular podocytes exposed to high glucose, inhibitors of both NADPH and mitochondrial metabolism abrogate ROS formation (45).
Serum withdrawal from 293T cells results in the generation of ROS in mitochondria that
subsequently activate NADPH oxidase (28).
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The finding of increased HIF-1 levels could partly account for high glucoseinduced VEGF expression at 48 h. These high glucose-enhanced HIF-1 levels may be attributable to the secondary release of growth factors or to increased ROS levels, given the recent finding that ROS are generated by NADPH oxidase in response to insulinaugmented HIF-1 levels (5). Enhanced HIF-1 protein levels have previously been noted in high glucose-treated mesangial cells (54) and in GLUT1 over expressing mesangial cells, where they were partly responsible for elevated VEGF expression (37) . 
